• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心源性休克患者行体外膜肺氧合治疗的生存预后:哪种乳酸最有用?

Survival on Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock: Which Lactate Is Most Useful?

机构信息

From the Internal Medicine Physician at Online Care Group, Chicago, Illinois.

University of Kentucky College of Medicine, Lexington, Kentucky.

出版信息

ASAIO J. 2022 Jan 1;68(1):41-45. doi: 10.1097/MAT.0000000000001413.

DOI:10.1097/MAT.0000000000001413
PMID:33769350
Abstract

Prognostic significance of elevated serum lactate in patients on venoarterial extracorporeal membrane oxygenation (ECMO) is widely known. Our objective was to study the utility of lactate measured at different points of time and lactate clearance in predicting the two study endpoints: successful ECMO weaning and hospital survival. Among 238 consecutive patients treated with ECMO, lactic acid was collected before initiating ECMO and then on days 1, 3, 5, and 10 while on ECMO. Out of our cohort, 129 (54.2%) were successfully weaned and 98 (41.2%) were discharged alive. Patients successfully weaned from ECMO had a significantly lower lactic acid level pre-ECMO (p = 0.001), at day 1 (p < 0.001), day 3 (p < 0.001), and day 5 (p = 0.001), compared with unsuccessfully weaned patients. Also, patients who survived hospitalization had significantly lower lactic acid pre-ECMO (p = 0.007), at day 1 (p < 0.001), day 3 (p = 0.001), and day 5 (p = 0.001), compared with those who died in-hospital. With regard to hospital survival, day 3 lactic acid was superior to pre-ECMO lactic acid (p = 0.0385), lactic acid on day 1, lactic acid reduction from pre-ECMO to day 1 (p = 0.0177) and from pre-ECMO to day 3 (p = 0.0361), and a day 3 lactic acid ≤ 1.7 meq/L was the optimal value that predicted hospital survival. On multivariable analysis, day 3 lactic acid independently predicted hospital survival after covariate adjustment (odds ratio [OR], 0.505; 95% confidence interval [CI], 0.290-0.880; p = 0.016). In conclusion, the absolute level of lactic acid while on ECMO support is more important for prognosis than a pre-ECMO level or the magnitude of decline from pre-ECMO to on-ECMO.

摘要

动静脉体外膜肺氧合(ECMO)患者血清乳酸升高的预后意义已广为人知。我们的目的是研究不同时间点测量的乳酸和乳酸清除率在预测两个研究终点(ECMO 成功脱机和医院存活)中的效用。在 238 例连续接受 ECMO 治疗的患者中,在启动 ECMO 前采集乳酸,然后在 ECMO 期间的第 1、3、5 和 10 天采集。在我们的队列中,129 例(54.2%)成功脱机,98 例(41.2%)出院存活。与未成功脱机的患者相比,成功脱机的患者 ECMO 前乳酸水平(p = 0.001)、第 1 天(p < 0.001)、第 3 天(p < 0.001)和第 5 天(p = 0.001)明显较低。此外,存活出院的患者 ECMO 前乳酸水平(p = 0.007)、第 1 天(p < 0.001)、第 3 天(p = 0.001)和第 5 天(p = 0.001)明显低于住院期间死亡的患者。关于医院存活率,第 3 天乳酸优于 ECMO 前乳酸(p = 0.0385),第 1 天乳酸、ECMO 前至第 1 天乳酸下降(p = 0.0177)和 ECMO 前至第 3 天乳酸下降(p = 0.0361),第 3 天乳酸≤1.7 meq/L 是预测医院存活率的最佳值。多变量分析显示,调整协变量后,第 3 天乳酸独立预测医院存活率(比值比[OR],0.505;95%置信区间[CI],0.290-0.880;p = 0.016)。总之,ECMO 支持时乳酸的绝对水平对预后比 ECMO 前水平或从 ECMO 前到 ECMO 期间的下降幅度更重要。

相似文献

1
Survival on Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock: Which Lactate Is Most Useful?心源性休克患者行体外膜肺氧合治疗的生存预后:哪种乳酸最有用?
ASAIO J. 2022 Jan 1;68(1):41-45. doi: 10.1097/MAT.0000000000001413.
2
Risk factors of in-hospital mortality in adult postcardiotomy cardiogenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation.体外膜肺氧合成功撤机后成年心脏手术后心源性休克患者院内死亡的危险因素。
Perfusion. 2020 Jul;35(5):417-426. doi: 10.1177/0267659119890214. Epub 2019 Dec 19.
3
Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.血乳酸作为需要体外膜肺氧合的小儿难治性心源性休克死亡率的可靠标志物。
Pediatr Cardiol. 2019 Mar;40(3):602-609. doi: 10.1007/s00246-018-2033-2. Epub 2019 Jan 2.
4
Predictors for unsuccessful weaning from venoarterial extracorporeal membrane oxygenation in patients undergoing coronary artery bypass grafting.冠状动脉搭桥手术患者静脉-动脉体外膜肺氧合脱机失败的预测因素
Perfusion. 2020 Oct;35(7):598-607. doi: 10.1177/0267659119900124. Epub 2020 Jan 21.
5
The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study.体外膜肺氧合支持下心内直视术后患者乳酸的早期动态变化与死亡率相关:一项回顾性观察研究。
J Thorac Cardiovasc Surg. 2015 May;149(5):1445-50. doi: 10.1016/j.jtcvs.2014.11.052. Epub 2014 Nov 24.
6
Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.儿童难治性心源性疾病行血管外膜氧合治疗的结局。
Eur J Pediatr. 2019 Jun;178(6):783-793. doi: 10.1007/s00431-019-03352-5. Epub 2019 Mar 4.
7
VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.非手术难治性心源性休克患者的VA-ECMO支持:植入前结局预测因素
Artif Organs. 2019 Feb;43(2):132-141. doi: 10.1111/aor.13331. Epub 2018 Nov 6.
8
Lactate levels as a prognostic predict in cardiogenic shock under venoarterial extracorporeal membrane oxygenation support.在静脉动脉体外膜肺氧合支持下,乳酸水平作为心源性休克的预后预测指标。
Rev Esp Cardiol (Engl Ed). 2022 Jul;75(7):595-603. doi: 10.1016/j.rec.2021.08.020. Epub 2021 Nov 19.
9
Predictors of Survival to Discharge After Successful Weaning From Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.心源性休克患者成功撤机后存活至出院的预测因素。
Circ J. 2020 Nov 25;84(12):2205-2211. doi: 10.1253/circj.CJ-20-0550. Epub 2020 Oct 10.
10
Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shock.心源性休克中静脉动脉体外膜肺氧合的时间进程、相关因素及其对预后的影响。
ESC Heart Fail. 2023 Feb;10(1):568-577. doi: 10.1002/ehf2.14132. Epub 2022 Nov 11.

引用本文的文献

1
Outcomes and risk factors of transported patients with extracorporeal membrane oxygenation: An ECMO center experience.体外膜肺氧合转运患者的结局及危险因素:一家体外膜肺氧合中心的经验
J Intensive Med. 2024 Jun 14;5(1):35-42. doi: 10.1016/j.jointm.2024.04.003. eCollection 2025 Jan.
2
Comparing clinical only and combined clinical laboratory models for ECPR outcomes in refractory cardiac arrest.比较仅基于临床因素和临床与实验室指标相结合的模型对难治性心脏骤停患者实施体外心肺复苏术(ECPR)的预后情况。
Sci Rep. 2025 Jan 23;15(1):2915. doi: 10.1038/s41598-025-87200-7.
3
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock.
心源性休克患者静脉-动脉体外膜肺氧合治疗脱机失败的发生率及预测因素
Eur J Heart Fail. 2025 May;27(5):832-841. doi: 10.1002/ejhf.3583. Epub 2025 Jan 17.
4
Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review.与成功撤机 veno-arterial 体外膜肺氧合相关的参数:系统评价。
Crit Care. 2022 Dec 5;26(1):375. doi: 10.1186/s13054-022-04249-w.
5
Influence of Venoarterial Extracorporeal Membrane Oxygenation Integrated Hemoadsorption on the Early Reversal of Multiorgan and Microcirculatory Dysfunction and Outcome of Refractory Cardiogenic Shock.静脉-动脉体外膜肺氧合联合血液吸附对多器官及微循环功能障碍早期逆转及难治性心源性休克预后的影响
J Clin Med. 2022 Nov 2;11(21):6517. doi: 10.3390/jcm11216517.